Telix to Participate in UBS Global Biopharma Conference
- Wednesday, November 11, 2026, 2:12
- PR Newswire
- Add a comment
MELBOURNE, Australia and INDIANAPOLIS, Nov. 11, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will participate in the upcoming UBS Global Biopharma Conference in London (UK). Dr. Christian Behrenbruch, Managing Director and Group CEO, and Mr. Richard…
About the Author
admin has written 22060 stories on this site.